Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study
Chang Hyun Nam1*, Ja Min Byun1-3*, Dong-Yeop Shin1,3, Junshik Hong1,3, Inho Kim1, Sung-soo Yoon1-3, Youngil Koh1,3
1Department of Internal Medicine, 2Biomedical Research Institute, Seoul National University Hospital, 3Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
Correspondence to: Youngil Koh M.D., Ph.D.
Department of Internal Medicine, Seoul National University Hospital, 101, Daehak-ro, Jongro-gu, Seoul 03080, Korea
E-mail go01@snu.ac.kr
*These authors contributed equally to this work.
Published online: August 30, 2021.
© The Korean Journal of Hematology. All rights reserved.



e-submission

This Article

Current Issue

ba_link01

SCImago Journal & Country Rank

Indexed/Covered by

Today : 290  /
Total : 335,376